Spectrum Pharma Jumps on FDA Orphan Designation
Spectrum Pharmaceuticals announced that the FDA has granted seven years of Orphan Drug exclusivity for Evomela.
All Work
Chris Lange
Cara Therapeutics Rises on FDA Judgment
Cara Therapeutics saw its shares jump early on Wednesday after it announced that it has received notice from the FDA that it has removed the clinical hold on its adaptive Phase 3 trial of…
Intel Earnings Skewed by Layoffs
Intel Corp. (NASDAQ: INTC) reported its first-quarter financial results after the markets closed on Tuesday. The company had $0.54 in earnings per share (EPS) on $13.8 billion in revenue compared to consensus estimates from…
Supervielle Group Prepares for IPO
Supervielle Group has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Gemphire Therapeutics Gears Up for IPO
Gemphire Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
How the Most Negative IBM Analyst Sees It After Earnings
Credit Suisse reiterated an Underperform rating with a price target that implies downside of roughly 24% from the current price level.
What to Look for in Coca-Cola Earnings
Coca-Cola is expected to report its first-quarter financial results before the markets open on Wednesday.
SEC Charges LA Firm With Defrauding Investors
The SEC has charged a litigation marketing company based out of Los Angeles, as well as its co-founders, with defrauding retirees and other investors.
What to Expect From Intel Earnings
Intel is scheduled to report its first-quarter financial results after the markets close on Tuesday.
Northern Trust Beats on Both Top and Bottom Lines
Northern Trust released better-than-expected first-quarter earnings report before the markets opened on Tuesday.
Goldman Sachs Crosses the Tape With Mixed Results
Goldman Sachs reported mixed first-quarter financial results before the markets opened on Tuesday.
Top 8 Dow Tech and Finance Earnings for the Coming Week
24/7 Wall St. has put together a preview of some of the top Dow tech and financial companies reporting their quarterly results this week.
6 Top Dow Earnings for the Week Ahead
24/7 Wall St. has put together a preview of the top Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Are Analysts Realistic on Clovis Oncology Now?
Shares of Clovis Oncology dropped after the FDA Oncologic Drugs Advisory Committee voted against its lung cancer drug.
5 Companies That Destroyed Shareholders Last Week
Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders. These companies hurt their shareholders last week.
How Analysts Rate Juniper After the Warning
Juniper Networks saw its shares sink early in the week following the announcement of its preliminary financial results.
Is PTC Therapeutics on the Road to Recovery?
PTC Therapeutics saw its shares jump late Friday morning on positive news on its nonsense mutation Duchenne muscular dystrophy treatment.
Vermont Ski Resort Faces Fraud Charges and Asset Freeze From SEC
The SEC has announced fraud charges and an asset freeze against a Vermont-based ski resort for allegedly misusing millions of dollars.
SEC Charges Town Officials in New York With Fraud and Hiding Financial Troubles
The SEC has announced fraud charges against Ramapo, N.Y., its local development corporation, and four town officials who allegedly hid a deteriorating financial situation from municipal bond investors.
Red Rocks Resorts Announces Potential Pricing of IPO
Red Rocks Resorts intends to price more than 27 million shares in the expected price range of $18 to $21 per share in and initial public offering valued up to about $658 million.